ATOMERA INC(NASDAQ:ATOM) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ATOM. ATOM was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. While ATOM seems to be doing ok healthwise, there are quite some concerns on its profitability. ATOM does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ATOM has reported negative net income.

ATOM had a negative operating cash flow in the past year.

ATOM had negative earnings in each of the past 5 years.

ATOM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -63.30%, ATOM is not doing good in the industry: 89.91% of the companies in the same industry are doing better.

With a Return On Equity value of -73.51%, ATOM is not doing good in the industry: 84.40% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-63.3%
ROE	-73.51%
ROIC	N/A

ROA(3y)-70.3%

ROA(5y)-58.45%

ROE(3y)-89.43%

ROE(5y)-72.7%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ATOM has a worse Gross Margin (8.89%) than 88.99% of its industry peers.

ATOM's Gross Margin has declined in the last couple of years.

ATOM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	8.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-55.37%

GM growth 5Y-29.98%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ATOM does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ATOM has been increased compared to 1 year ago.

Compared to 5 years ago, ATOM has more shares outstanding

Compared to 1 year ago, ATOM has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 7.27 indicates that ATOM is not in any danger for bankruptcy at the moment.

With a decent Altman-Z score value of 7.27, ATOM is doing good in the industry, outperforming 73.39% of the companies in the same industry.

A Debt/Equity ratio of 0.02 indicates that ATOM is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.02, ATOM is in the better half of the industry, outperforming 62.39% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Altman-Z	7.27

ROIC/WACCN/A

WACC10.97%

2.3 Liquidity

A Current Ratio of 7.58 indicates that ATOM has no problem at all paying its short term obligations.

The Current ratio of ATOM (7.58) is better than 92.66% of its industry peers.

ATOM has a Quick Ratio of 7.58. This indicates that ATOM is financially healthy and has no problem in meeting its short term obligations.

ATOM's Quick ratio of 7.58 is amongst the best of the industry. ATOM outperforms 95.41% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.58
Quick Ratio	7.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.11% over the past year.

The Revenue for ATOM has decreased by -75.45% in the past year. This is quite bad

Measured over the past years, ATOM shows a very negative growth in Revenue. The Revenue has been decreasing by -23.93% on average per year.

EPS 1Y (TTM)11.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.14%

Revenue 1Y (TTM)-75.45%

Revenue growth 3Y-30.38%

Revenue growth 5Y-23.93%

Sales Q2Q%-95.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y3.46%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year800%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATOM. In the last year negative earnings were reported.

Also next year ATOM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ATOM!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ATOMERA INC

NASDAQ:ATOM (4/25/2025, 8:00:00 PM)

After market: 4.4487 +0.19 (+4.43%)

4.26

+0.05 (+1.31%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)02-11 2025-02-11/amc

Earnings (Next)05-06 2025-05-06

Inst Owners28.41%

Inst Owner Change0.12%

Ins Owners4.33%

Ins Owner Change20.19%

Market Cap130.78M

Analysts82.86

Price Target7.14 (67.61%)

Short Float %15.87%

Short Ratio8.77

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)8.73%

Min EPS beat(2)8.5%

Max EPS beat(2)8.96%

EPS beat(4)3

Avg EPS beat(4)6.98%

Min EPS beat(4)-4.58%

Max EPS beat(4)15.03%

EPS beat(8)6

Avg EPS beat(8)1.13%

EPS beat(12)10

Avg EPS beat(12)4.32%

EPS beat(16)12

Avg EPS beat(16)1.06%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)-17.78%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)-100%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-68.97%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	968.76
P/FCF	N/A
P/OCF	N/A
P/B	5.22
P/tB	5.22
EV/EBITDA	N/A

EPS(TTM)-0.56

EYN/A

EPS(NY)-0.54

Fwd EYN/A

FCF(TTM)-0.43

FCFYN/A

OCF(TTM)-0.43

OCFYN/A

SpS0

BVpS0.82

TBVpS0.82

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-63.3%
ROE	-73.51%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	8.89%
FCFM	N/A

ROA(3y)-70.3%

ROA(5y)-58.45%

ROE(3y)-89.43%

ROE(5y)-72.7%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-55.37%

GM growth 5Y-29.98%

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	1.24%
Cap/Sales	10.37%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	7.58
Quick Ratio	7.58
Altman-Z	7.27

F-Score4

WACC10.97%

ROIC/WACCN/A

Cap/Depr(3y)2.28%

Cap/Depr(5y)70.03%

Cap/Sales(3y)8.84%

Cap/Sales(5y)54.14%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)11.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.14%

EPS Next Y3.46%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-75.45%

Revenue growth 3Y-30.38%

Revenue growth 5Y-23.93%

Sales Q2Q%-95.82%

Revenue Next Year800%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y6.49%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y9.17%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y9.07%

OCF growth 3YN/A

OCF growth 5YN/A

ATOMERA INC (ATOM) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens